BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 579835)

  • 61. [Cytologic picture of smears from the cervix uteri of women using intrauterine contraceptive devices (IUD)].
    Wagrowska-Danilewicz M; Gwóźdź AZ; Danilewicz M
    Ginekol Pol; 1988 Dec; 59(12):724-7. PubMed ID: 3254840
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Three-dimensional ultrasound detection of abnormally located intrauterine contraceptive devices which are a source of pelvic pain and abnormal bleeding.
    Benacerraf BR; Shipp TD; Bromley B
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):110-5. PubMed ID: 19565532
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
    Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
    Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A national study to monitor the safety of IUCD use.
    Richardson A; Paul C
    Contraception; 1993 Apr; 47(4):359-66. PubMed ID: 8508665
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanism of action of intrauterine devices: biochemical changes.
    Johannisson E
    Contraception; 1987 Jul; 36(1):11-22. PubMed ID: 3311620
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A three-year study of the copper T 200 intrauterine device.
    Gupta HD; Devi PK
    Contraception; 1976 Aug; 14(2):165-9. PubMed ID: 949893
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IUD in first-trimester abortion: immediate intrauterine contraceptive devices insertion vs delayed insertion following the next menstruation bleeding.
    Tsikouras P; Vrachnis N; Grapsa A; Tsagias N; Pinidis P; Liberis A; Ammari A; Grapsas X; Galazios G; Liberis V
    Arch Gynecol Obstet; 2014 Jul; 290(1):99-105. PubMed ID: 24573506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ultrastructural alterations in human endometrium caused by intrauterine contraceptive devices.
    Verma V
    Int J Gynaecol Obstet; 1981 Jun; 19(3):211-9. PubMed ID: 6120868
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD.
    Milsom I; Rybo G; Lindstedt G
    Contraception; 1990 Mar; 41(3):271-81. PubMed ID: 2323218
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organisms.
    Mao K; Guillebaud J
    Contraception; 1984 Dec; 30(6):535-44. PubMed ID: 6529911
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Study on the relationship between uterine bleeding with intrauterine device and viral infection].
    Xu H; Tian X; Li F
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):414-6. PubMed ID: 7587578
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
    Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
    Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New developments in intrauterine devices.
    Farr G
    Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Today's IUDs offer safe, effective contraception.
    Finger WR
    Netw Res Triangle Park N C; 1993 Mar; 13(3):12-5. PubMed ID: 12318094
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intrauterine devices and pelvic inflammatory disease: recent developments.
    Grimes DA
    Contraception; 1987 Jul; 36(1):97-109. PubMed ID: 3311628
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IUD use and unexplained vaginal bleeding.
    Huggins GR
    Obstet Gynecol; 1981 Oct; 58(4):409-16. PubMed ID: 7279336
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The safety of intrauterine devices.
    Guillebaud J
    Stud Fam Plann; 1979 May; 10(5):174-7. PubMed ID: 483342
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of various IUDs on the composition of cervical mucus.
    Jonsson B; Landgren BM; Eneroth P
    Contraception; 1991 May; 43(5):447-58. PubMed ID: 1914458
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adolescent Experiences With Intrauterine Devices: A Qualitative Study.
    Schmidt EO; James A; Curran KM; Peipert JF; Madden T
    J Adolesc Health; 2015 Oct; 57(4):381-6. PubMed ID: 26126950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.